| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7882c4cb938cdb986cbb1166f199d475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1935edddf0a4cba21b2ce94b0249f8f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dee559a65f8b5aaf0fa389b834d31919
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e1f3e44b424f6f56df89832f67780c |
| publicationDate |
2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014205244-A1 |
| titleOfInvention |
Methods for enhancing effectiveness of medical therapies |
| abstract |
Methods are provided herein for enhancing the effectiveness of medical therapies by administering agents that suppress a biological damage response comprising cellular senescence that is induced by the medical therapy administered to a subject. In certain embodiments, a method is provided for ameliorating toxicity of the medical therapy comprising administering an anti-senescent cell agent that destroys or facilitates destruction of the senescent cells. In certain embodiments, methods are provided for ameliorating toxicity of the medical therapy and for inhibiting metastasis of cancer in a subject who has cancer and receives the medical therapy by administering an anti-senescent cell agent that destroys or facilitates destruction of the senescent cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517572-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019212933-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3669881-A1 |
| priorityDate |
2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |